| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |